Improving Huntington’s disease drug discovery with new reproducible disease models
This webinar explores how a new generation of reproducible and scalable human cell models are being utilised for drug discovery in Huntington’s disease.
In this webinar, our Senior Scientist – Neurobiology, Dr Emma Jones and Dr Tony Oosterveen from bit.bio will offer an expert discussion on how stem cells are being reprogrammed into new, accurate and reproducible Huntington’s disease models for drug discovery.
